Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin? (Q38077655)

28 August 2017

1 reference

title

Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin? (English)

1 reference

28 August 2017

1 reference

3

M J Soares

1 reference

28 August 2017

E K Calton

1

1 reference

PubMed ID

23361156

28 August 2017

V S Miller

series ordinal

2

1 reference

28 August 2017

30 January 2013

1 reference

European Journal of Clinical Nutrition

28 August 2017

1 reference

28 August 2017

67

1 reference

28 August 2017

5

1 reference

28 August 2017

485-491

1 reference

https://scigraph.springernature.com/pub.10.1038/ejcn.2013.1

28 August 2017

0 references

cites work

Testosterone and metabolic syndrome: a meta-analysis study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin as a biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin: more than just another fat cell hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin--a key adipokine in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Obesity and inflammation: the effects of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Inflammation and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, random

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Self-poisoning in rural Sri Lanka: small-area variations in incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a french prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Is vitamin D status relevant to metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Effects of whey protein isolate on body composition, lipids, insulin and glucose in overweight and obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Plasma adiponectin response to acute exercise in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

The effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin and stress hormone responses to maximal sculling after volume-extended training season in elite rowers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Exercise training reverses adiponectin resistance in skeletal muscle of patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Is impaired energy regulation the core of the metabolic syndrome in various ethnic groups of the USA and Taiwan?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Mitochondrial fitness and insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Could mitochondrial efficiency explain the susceptibility to adiposity, metabolic syndrome, diabetes and cardiovascular diseases in South Asian populations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Mitochondrial oxygen affinity predicts basal metabolic rate in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Energy metabolism and the metabolic syndrome: does a lower basal metabolic rate signal recovery following weight loss?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Evolving concepts on adjusting human resting energy expenditure measurements for body size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Metabolically active components of fat-free mass and resting energy expenditure in humans: recent lessons from imaging technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin acts in the brain to decrease body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: parameters associated with adiponectin complex distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Association of adiponectin with hypertension in type 2 diabetic patients: the gender effect.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Design of a RCT evaluating the (cost-) effectiveness of a lifestyle intervention for male construction workers at risk for cardiovascular disease: the health under construction study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Commentary: testosterone and the metabolic syndrome: cause or consequence?

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Impact of age on leptin and adiponectin independent of adiposity

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Association between dietary factors and plasma adiponectin concentrations in men.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: cause or effect?

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Mitochondrial Respiration Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.1

7 January 2021

Identifiers

DOI

10.1038/EJCN.2013.1

1 reference

PubMed ID

23361156

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23361156